Characteristics of Hospitals Exiting the Newly Voluntary Comprehensive Care for Joint Replacement Program

Hyunjee Kim; Thomas H.A. Meath; Jenny I. Grunditz; Ana R. Quiñones; Said A. Ibrahim; K. John McConnell

doi:10.1001/jamainternmed.2018.4743

Characteristics of Hospitals Exiting the Newly Voluntary Comprehensive Care for Joint Replacement Program

Hyunjee Kim, Thomas H.A. Meath, Jenny I. Grunditz, Ana R. Quiñones, Said A. Ibrahim, K. John McConnell

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1715-1717
Number of pages	3
Journal	JAMA internal medicine
Volume	178
Issue number	12
DOIs	https://doi.org/10.1001/jamainternmed.2018.4743
State	Published - Dec 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/jamainternmed.2018.4743

Cite this

@article{bd345b241fe540bd8e4ae89fd67fe179,

title = "Characteristics of Hospitals Exiting the Newly Voluntary Comprehensive Care for Joint Replacement Program",

author = "Hyunjee Kim and Meath, {Thomas H.A.} and Grunditz, {Jenny I.} and Qui{\~n}ones, {Ana R.} and Ibrahim, {Said A.} and McConnell, {K. John}",

note = "Funding Information: Conflict of Interest Disclosures: Mr Khan reported receiving research funding from AbbVie and Ferring Pharmaceuticals. Dr Grover reported receiving grants from AbbVie and Janssen and personal fees from AbbVie, Takeda, and Ferring and being owner of and holding shares in Volō Healthcare.",

year = "2018",

month = dec,

doi = "10.1001/jamainternmed.2018.4743",

language = "English (US)",

volume = "178",

pages = "1715--1717",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Characteristics of Hospitals Exiting the Newly Voluntary Comprehensive Care for Joint Replacement Program

AU - Kim, Hyunjee

AU - Meath, Thomas H.A.

AU - Grunditz, Jenny I.

AU - Quiñones, Ana R.

AU - Ibrahim, Said A.

AU - McConnell, K. John

N1 - Funding Information: Conflict of Interest Disclosures: Mr Khan reported receiving research funding from AbbVie and Ferring Pharmaceuticals. Dr Grover reported receiving grants from AbbVie and Janssen and personal fees from AbbVie, Takeda, and Ferring and being owner of and holding shares in Volō Healthcare.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85055327321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055327321&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2018.4743

DO - 10.1001/jamainternmed.2018.4743

M3 - Letter

C2 - 30422206

AN - SCOPUS:85055327321

SN - 2168-6106

VL - 178

SP - 1715

EP - 1717

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 12

ER -

Characteristics of Hospitals Exiting the Newly Voluntary Comprehensive Care for Joint Replacement Program

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this